These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

360 related articles for article (PubMed ID: 26820274)

  • 1. What Is the Evidence for Harm of Neuromuscular Blockade and Corticosteroid Use in the Intensive Care Unit?
    Annane D
    Semin Respir Crit Care Med; 2016 Feb; 37(1):51-6. PubMed ID: 26820274
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Markov computer simulation model of the economics of neuromuscular blockade in patients with acute respiratory distress syndrome.
    Macario A; Chow JL; Dexter F
    BMC Med Inform Decis Mak; 2006 Mar; 6():15. PubMed ID: 16539706
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuromuscular Blockade in the 21st Century Management of the Critically Ill Patient.
    deBacker J; Hart N; Fan E
    Chest; 2017 Mar; 151(3):697-706. PubMed ID: 27818334
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Recommendations of the Infectious Diseases Work Group (GTEI) of the Spanish Society of Intensive and Critical Care Medicine and Coronary Units (SEMICYUC) and the Infections in Critically Ill Patients Study Group (GEIPC) of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC) for the diagnosis and treatment of influenza A/H1N1 in seriously ill adults admitted to the Intensive Care Unit].
    Rodríguez A; Alvarez-Rocha L; Sirvent JM; Zaragoza R; Nieto M; Arenzana A; Luque P; Socías L; Martín M; Navarro D; Camarena J; Lorente L; Trefler S; Vidaur L; Solé-Violán J; Barcenilla F; Pobo A; Vallés J; Ferri C; Martín-Loeches I; Díaz E; López D; López-Pueyo MJ; Gordo F; del Nogal F; Marqués A; Tormo S; Fuset MP; Pérez F; Bonastre J; Suberviola B; Navas E; León C; ; ;
    Med Intensiva; 2012 Mar; 36(2):103-37. PubMed ID: 22245450
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intensive care unit-acquired weakness: risk factors and prevention.
    de Jonghe B; Lacherade JC; Sharshar T; Outin H
    Crit Care Med; 2009 Oct; 37(10 Suppl):S309-15. PubMed ID: 20046115
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Best evidence in critical care medicine: The role of neuromuscular blocking drugs in early severe acute respiratory distress syndrome.
    Needham CJ; Brindley PG
    Can J Anaesth; 2012 Jan; 59(1):105-8. PubMed ID: 22042702
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical Practice Guidelines for Sustained Neuromuscular Blockade in the Adult Critically Ill Patient.
    Murray MJ; DeBlock H; Erstad B; Gray A; Jacobi J; Jordan C; McGee W; McManus C; Meade M; Nix S; Patterson A; Sands MK; Pino R; Tescher A; Arbour R; Rochwerg B; Murray CF; Mehta S
    Crit Care Med; 2016 Nov; 44(11):2079-2103. PubMed ID: 27755068
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current therapeutic uses, pharmacology, and clinical considerations of neuromuscular blocking agents for critically ill adults.
    Warr J; Thiboutot Z; Rose L; Mehta S; Burry LD
    Ann Pharmacother; 2011 Sep; 45(9):1116-26. PubMed ID: 21828347
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Corticosteroids and neuromuscular blockers in development of critical illness neuromuscular abnormalities: A historical review.
    Wilcox SR
    J Crit Care; 2017 Feb; 37():149-155. PubMed ID: 27736708
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of community-acquired, hospital-acquired, and intensive care unit-acquired acute respiratory distress syndrome: a prospective observational cohort study.
    Kao KC; Hu HC; Hsieh MJ; Tsai YH; Huang CC
    Crit Care; 2015 Nov; 19():384. PubMed ID: 26530427
    [TBL] [Abstract][Full Text] [Related]  

  • 11. To Block or Not: Updates in Neuromuscular Blockade in Acute Respiratory Distress Syndrome.
    Mefford B; Donaldson JC; Bissell BD
    Ann Pharmacother; 2020 Sep; 54(9):899-906. PubMed ID: 32111121
    [No Abstract]   [Full Text] [Related]  

  • 12. Driving pressure and acute respiratory distress syndrome in critically ill patients.
    Blondonnet R; Joubert E; Godet T; Berthelin P; Pranal T; Roszyk L; Chabanne R; Eisenmann N; Lautrette A; Belville C; Cayot S; Gillart T; Souweine B; Bouvier D; Blanchon L; Sapin V; Pereira B; Constantin JM; Jabaudon M
    Respirology; 2019 Feb; 24(2):137-145. PubMed ID: 30183115
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of neuromuscular blockers in ARDS: benefits and risks.
    Hraiech S; Forel JM; Papazian L
    Curr Opin Crit Care; 2012 Oct; 18(5):495-502. PubMed ID: 22941207
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Corticosteroid use in the intensive care unit: a survey of intensivists.
    Lamontagne F; Quiroz Martinez H; Adhikari NK; Cook DJ; Koo KK; Lauzier F; Turgeon AF; Kho ME; Burns KE; Chant C; Fowler R; Douglas I; Poulin Y; Choong K; Ferguson ND; Meade MO
    Can J Anaesth; 2013 Jul; 60(7):652-9. PubMed ID: 23606231
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute Management and Long-Term Survival Among Subjects With Severe Middle East Respiratory Syndrome Coronavirus Pneumonia and ARDS.
    Khalid I; Alraddadi BM; Dairi Y; Khalid TJ; Kadri M; Alshukairi AN; Qushmaq IA
    Respir Care; 2016 Mar; 61(3):340-8. PubMed ID: 26701365
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute lung injury and acute respiratory distress syndrome requiring tracheal intubation and mechanical ventilation in the intensive care unit: impact on managing uncertainty for patient-centered communication.
    Johnson RF; Gustin J
    Am J Hosp Palliat Care; 2013 Sep; 30(6):569-75. PubMed ID: 23015728
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The use of neuromuscular blocking agents in the ICU: where are we now?
    Greenberg SB; Vender J
    Crit Care Med; 2013 May; 41(5):1332-44. PubMed ID: 23591211
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of neuromuscular blocking agents uses in acute respiratory distress syndrome: a systematic review and meta-analysis of randomized controlled trials.
    Lyu T; Lee YS; Dhanvijay S; Freebairn R
    Minerva Anestesiol; 2021 Mar; 87(3):341-350. PubMed ID: 33300324
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical study of early use of neuromuscular blocking agents in patients with severe sepsis and acute respiratory distress syndrome].
    Lyu G; Wang X; Jiang W; Cai T; Zhang Y
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2014 May; 26(5):325-9. PubMed ID: 24809261
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Are corticosteroids useful in late-stage acute respiratory distress syndrome?
    Sessler CN; Gay PC
    Respir Care; 2010 Jan; 55(1):43-55. PubMed ID: 20040123
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.